Results 211 to 220 of about 19,730 (233)

Additional Inhibition of Wnt/β-Catenin Signaling by Metformin in DAA Treatments as a Novel Therapeutic Strategy for HCV-Infected Patients

Cells, 2021
Yücel Aydin, Ali Riza Koksal, Adriana Lopez   +2 more
exaly  

SON of DAA

Chemical & Engineering News Archive, 1971
openaire   +1 more source

Low risk of HBV reactivation in a large European cohort of HCV/HBV coinfected patients treated with DAA

Expert Review of Anti-Infective Therapy, 2020
Krzysztof Tomasiewicz, Wlodzimierz Mazur, Olga Tronina   +2 more
exaly  

DAA-based antiviral treatment of patients with chronic hepatitis C in the pre- and postkidney transplantation setting

Transplant International, 2016
Sandra Beinhardt, Michael Trauner, Rudolf Stauber   +2 more
exaly  

Interferon- and ribavirin-free therapy with new direct acting antivirals (DAA) for chronic hepatitis C improves vascular endothelial function

International Journal of Cardiology, 2018
Thomas Muenzel, Peter Robert Galle, Jorn M Schattenberg   +2 more
exaly  

DaaS Development

Wiehann Olivier, Pieter Buys
openaire   +1 more source

Protective and anti-arthritic effects of deer antler aqua-acupuncture (DAA), inhibiting dihydroorotate dehydrogenase, on phosphate ions-mediated chondrocyte apoptosis and rat collagen-induced arthritis

International Immunopharmacology, 2004
Sangho Moon, Cheorl-Ho Kim, Young Guk Park   +2 more
exaly  

Access to DAA therapy, and the role of DAAs in targeted HCV elimination

Elena Vargas-Accarino, Rafael Esteban, María Buti   +2 more
openaire   +1 more source

Immune responses in DAA treated chronic hepatitis C patients with and without prior RG-101 dosing

Antiviral Research, 2017
Anthony Brown, Neeltje A Kootstra, Leo Swadling   +2 more
exaly  

Molecular Mechanisms of Resistance to Direct-Acting Antiviral (DAA) Drugs for the Treatment of Hepatitis C Virus Infections

Diagnostics, 2023
exaly